Related references
Note: Only part of the references are listed.Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study
Antoinette R. Tan et al.
LANCET ONCOLOGY (2021)
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
D. M. Weinreich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Overcoming challenges in co-formulation of proteins with contradicting stability profiles - EPO plus G-CSF
Dennis Krieg et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Analytical characterization of coformulated antibodies as combination therapy
Jun Kim et al.
MABS (2020)
Biophysical Characterization of Binary Therapeutic Monoclonal Antibody Mixtures
Dennis Krieg et al.
MOLECULAR PHARMACEUTICS (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Stability enhancement in a mAb and Fab coformulation
Hongyu Zhang et al.
SCIENTIFIC REPORTS (2020)
Determination of Protein-Protein Interactions in a Mixture of Two Monoclonal Antibodies
Priyanka Singh et al.
MOLECULAR PHARMACEUTICS (2019)
Challenges for the pharmaceutical technical development of protein coformulations
Claudia Mueller et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2018)
CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises
Bing Tong et al.
FUTURE ONCOLOGY (2018)
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates
Kristen E. Pascal et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Computational Design To Reduce Conformational Flexibility and Aggregation Rates of an Antibody Fab Fragment
Cheng Zhang et al.
MOLECULAR PHARMACEUTICS (2018)
An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and E
Mingxiang Li et al.
PLOS ONE (2018)
Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability Studies
Ashaben Patel et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Viscosities and Protein Interactions of Bispecific Antibodies and Their Monospecific Mixtures
Mahlet A. Woldeyes et al.
MOLECULAR PHARMACEUTICS (2018)
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
[Anonymous]
NATURE REVIEWS DRUG DISCOVERY (2018)
Sym015: A Highly Efficacious Antibody Mixture against MET-Amplified Tumors
Thomas Tuxen Poulsen et al.
CLINICAL CANCER RESEARCH (2017)
Kinetics of Monoclonal Antibody Aggregation from Dilute toward Concentrated Conditions
Lucrece Nicoud et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2016)
Mapping the Aggregation Kinetics of a Therapeutic Antibody Fragment
Nesrine Chakroun et al.
MOLECULAR PHARMACEUTICS (2016)
Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity
Helle J. Jacobsen et al.
CLINICAL CANCER RESEARCH (2015)
Combination cancer immunotherapy and new immunomodulatory targets
Kathleen M. Mahoney et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Ignacio Melero et al.
NATURE REVIEWS CANCER (2015)
Therapeutic protein aggregation: mechanisms, design, and control
Christopher J. Roberts
TRENDS IN BIOTECHNOLOGY (2014)
Insulin Degludec Aspart: The First Co-formulation of Insulin Analogues
Sanjay Kalra
DIABETES THERAPY (2014)
The emerging therapeutic role of antibody mixtures
Tadeusz Robak
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Concentration-Dependent Viscosity of Binary and Ternary Mixtures of Nonassociating Proteins: Measurement and Analysis
Asaf Grupi et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
Sym004, a Novel EGFR Antibody Mixture, Can Overcome Acquired Resistance to Cetuximab
Mari Iida et al.
NEOPLASIA (2013)
Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein
Q. Meng et al.
ANALYTICAL BIOCHEMISTRY (2012)
Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia
Tadeusz Robak et al.
BLOOD (2012)
Sym004: A Novel Synergistic Anti-Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy
Mikkel Wandahl Pedersen et al.
CANCER RESEARCH (2010)
Share Paper
